BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20334627)

  • 1. O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence.
    Weiman S; Uchiyama S; Lin FY; Chaffin D; Varki A; Nizet V; Lewis AL
    Biochem J; 2010 May; 428(2):163-8. PubMed ID: 20334627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus.
    Lewis AL; Cao H; Patel SK; Diaz S; Ryan W; Carlin AF; Thon V; Lewis WG; Varki A; Chen X; Nizet V
    J Biol Chem; 2007 Sep; 282(38):27562-71. PubMed ID: 17646166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact.
    Weiman S; Dahesh S; Carlin AF; Varki A; Nizet V; Lewis AL
    Glycobiology; 2009 Nov; 19(11):1204-13. PubMed ID: 19643844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The group B streptococcal sialic acid O-acetyltransferase is encoded by neuD, a conserved component of bacterial sialic acid biosynthetic gene clusters.
    Lewis AL; Hensler ME; Varki A; Nizet V
    J Biol Chem; 2006 Apr; 281(16):11186-92. PubMed ID: 16490781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual actions of group B
    Uchiyama S; Sun J; Fukahori K; Ando N; Wu M; Schwarz F; Siddiqui SS; Varki A; Marth JD; Nizet V
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7465-7470. PubMed ID: 30910970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.
    Lewis AL; Nizet V; Varki A
    Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11123-8. PubMed ID: 15263085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
    Wessels MR; Haft RF; Heggen LM; Rubens CE
    Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of neuD transcription levels and capsular sialic acid expression among serotype III group B Streptococcus strains.
    Lartigue MF; Poulard AF; Al Safadi R; Pailhories H; Domelier-Valentin AS; van der Mee-Marquet N; Rosenau A; Quentin R
    Microbiology (Reading); 2011 Dec; 157(Pt 12):3282-3291. PubMed ID: 21852348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.
    Carlin AF; Chang YC; Areschoug T; Lindahl G; Hurtado-Ziola N; King CC; Varki A; Nizet V
    J Exp Med; 2009 Aug; 206(8):1691-9. PubMed ID: 19596804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection.
    Kline KA; Schwartz DJ; Lewis WG; Hultgren SJ; Lewis AL
    Infect Immun; 2011 Sep; 79(9):3588-95. PubMed ID: 21690238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
    Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
    Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.
    Chaffin DO; Mentele LM; Rubens CE
    J Bacteriol; 2005 Jul; 187(13):4615-26. PubMed ID: 15968073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
    Carlin AF; Uchiyama S; Chang YC; Lewis AL; Nizet V; Varki A
    Blood; 2009 Apr; 113(14):3333-6. PubMed ID: 19196661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
    Segura M
    Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.
    Alhhazmi A; Pandey A; Tyrrell GJ
    J Clin Microbiol; 2017 Sep; 55(9):2637-2650. PubMed ID: 28615470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.
    Carlin AF; Lewis AL; Varki A; Nizet V
    J Bacteriol; 2007 Feb; 189(4):1231-7. PubMed ID: 16997964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Group B Streptococcus sialylated capsular polysaccharides with host Siglec-like molecules dampens the inflammatory response in tilapia.
    Dong J; Wei Y; Sun C; Tian Y; Hu J; Shi H; Zhang D; Lu M; Ye X
    Mol Immunol; 2018 Nov; 103():182-190. PubMed ID: 30291999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic acid-dependent interaction of group B streptococci with influenza virus-infected cells reveals a novel adherence and invasion mechanism.
    Tong J; Fu Y; Wu NH; Rohde M; Meng F; Valentin-Weigand P; Herrler G
    Cell Microbiol; 2018 Apr; 20(4):. PubMed ID: 29272058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of two group B streptococcal virulence factors.
    Rubens CE; Wessels MR; Kuypers JM; Kasper DL; Weiser JN
    Semin Perinatol; 1990 Aug; 14(4 Suppl 1):22-9. PubMed ID: 2173147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillin-binding proteins in Streptococcus agalactiae: a novel mechanism for evasion of immune clearance.
    Jones AL; Needham RH; Clancy A; Knoll KM; Rubens CE
    Mol Microbiol; 2003 Jan; 47(1):247-56. PubMed ID: 12492868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.